Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Charting a bullish July start, Nasdaq extends break to record territory
04:20pm, Tuesday, 07'th Jul 2020
Technically speaking, the major U.S. benchmarks are off to a constructive July start despite persistently uneven price action, writes Michael Ashbaugh.
B.Riley FBR Sticks to Its Buy Rating for Spectrum Pharmaceuticals (SPPI) - Markets
11:52am, Thursday, 02'nd Jul 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Spectrum Pharmaceuticals (SPPI – Research Report) today and set a
New Mexico Educational Retirement Board Has $685,000 Stock Holdings in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
09:14am, Wednesday, 01'st Jul 2020
New Mexico Educational Retirement Board boosted its holdings in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 37.6% during the 1st quarter, HoldingsChannel.com reports. The institutional in
Charting market cross currents, S&P 500 maintains 200-day average
04:47pm, Tuesday, 30'th Jun 2020
Technically speaking, the major U.S. benchmarks are poised to conclude June against an increasingly uneven, but still generally bullish, bigger-picture...
Chardan Capital Reaffirms Their Hold Rating on OncoCyte (OCX) - Markets
12:10pm, Tuesday, 30'th Jun 2020
In a report released today, Keay Nakae from Chardan Capital reiterated a Hold rating on OncoCyte (OCX – Research Report),
B.Riley FBR Reaffirms Their Buy Rating on Durect (DRRX) - Markets
06:45am, Monday, 29'th Jun 2020
In a report released today, Mayank Mamtani from B.Riley FBR reiterated a Buy rating on Durect (DRRX – Research Report),
Arrowhead Pharmaceuticals Is A Long-Term Investment To Consider
01:21am, Monday, 29'th Jun 2020
Arrowhead has a pipeline full of novel RNAi therapies, including 2 partnered programs with big pharma companies. Arrowhead has yet to get a product to market, b
Backer Marianne De Purchases 500 Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Stock
09:34am, Friday, 26'th Jun 2020
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Director Backer Marianne De bought 500 shares of the stock in a transaction on Monday, January 13th. The stock was purchased at an average price of $54.95 p
Wall Street Analysts Are Bullish on Top Services Picks - Markets
11:16am, Thursday, 25'th Jun 2020
There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on Sonnet BioTherapeutics
American Assets Trust, Inc (NYSE:AAT) Shares Sold by Parametric Portfolio Associates LLC
06:16am, Wednesday, 24'th Jun 2020
Parametric Portfolio Associates LLC trimmed its holdings in American Assets Trust, Inc (NYSE:AAT) by 17.4% during the first quarter, Holdings Channel reports. The institutional investor owned 143,000
Chardan Capital Reaffirms Their Buy Rating on ProQR (PRQR) - Markets
12:08pm, Tuesday, 23'rd Jun 2020
Chardan Capital analyst Keay Nakae reiterated a Buy rating on ProQR (PRQR – Research Report) today and set a price
Index Constituent Change – SYG4IR - SENS
06:00am, Tuesday, 23'rd Jun 2020
Sens announcement for Index Constituent Change – SYG4IR - SENS
6 Impressive Stocks To Watch Now
12:00am, Tuesday, 23'rd Jun 2020
Stocks Analysis by Harry Boxer covering: Compugen, Arrowhead Pharmaceuticals Inc, Overstockcom Inc, Synchronoss Technologies Inc. Read Harry Boxer's latest article on Investing.com
Agenus (AGEN) Receives a Buy from B.Riley FBR - Markets
05:08pm, Monday, 22'nd Jun 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Agenus (AGEN – Research Report) today and set a price
CymaBay Therapeutics (CBAY) Gets a Buy Rating from B.Riley FBR - Markets
07:20am, Monday, 22'nd Jun 2020
In a report released today, Mayank Mamtani from B.Riley FBR reiterated a Buy rating on CymaBay Therapeutics (CBAY – Research
